Milestone Scientific Appoints Scott Mahnken as New Director of Marketing

LIVINGSTON, N.J., Feb. 4 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. , the recognized leader in advanced injection technologies, today announced that Scott Mahnken has joined the Company's leadership team as new Director of Marketing. Tasked with developing and managing a wide range of strategic marketing and communications initiatives to promote corporate and product brand awareness and drive sales growth, Mahnken will report directly to Bob Presutti, Vice President of Sales and Marketing.

"Scott is a welcome addition to our team, bringing significant marketing expertise, important industry contacts and relationships, and a 20+ year proven history of success in achieving tangible, impressive results. His experience within the professional dental industry coupled with his demonstrated ability to drive sales through innovative, proactive marketing programs is sure to play a measurable role in aiding Milestone to advance its strategic growth objectives," noted Presutti. "We are particularly excited about Scott helping us to adopt more effective methods of using outbound telemarketing to promote greater customer support and product education, while also increasing sales of our disposable handpieces."

Immediately prior to joining Milestone, Mahnken served as Director of Partnership Relations at ArcMesa Educators, an organization dedicated to providing accredited continuing education to medical and dental providers. From 2000 through 2003, he served as Manager of Sales and Marketing and Product Manager of SS White Burs, Inc., the nation's oldest dental equipment manufacturer. While serving as Director of Sales at Lanmark Group, Inc. from 1994 through 2000, Mahnken managed the medical/dental ad agency's clients' inside and outside product sales initiatives where he doubled sales the first year and achieved 20% sales growth every year thereafter. From 1985 through 1994, he served as District Sales Manager for L'Oreal, a Fortune 500 health and beauty aids company. Mahnken is a graduate of the University of New Orleans, where he earned a Bachelors of Art degree in Business.

About Milestone Scientific Inc.

Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company's IP platform and product development strategy is its patented CompuFlo(TM) technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids. The Single Tooth Anesthesia (STA(TM)) computer-controlled local anesthesia delivery system which uses this technology provides dentists with audible and visual signals as to in-tissue pressure. Milestone's existing painless injection systems are currently sold in 25 countries. For more information on these and other innovative Milestone products, please visit the Company's web site found at http://www.milesci.com.

Safe Harbor Statement

This press release contains forward-looking statements regarding the timing and financial impact of the Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report on Form 10-KSB for the year ended December 31, 2006. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

mlss@efcg.net

CONTACT: Dodi Handy, President and CEO, or Daniel Conway, Chief
Strategist, both of Elite Financial Communications Group, LLC,
+1-407-585-1080, mlss@efcg.net, for Milestone Scientific Inc.

Web site: http://www.milesci.com/

Back to news